Senior Director, HEOR and Pricing

Role: Senior Director, HEOR & Pricing at Rocket Pharma, leading global strategies to demonstrate the clinical, economic, societal, and access value of gene therapies for rare genetic cardiomyopathies. Responsibilities: develop integrated value narratives, construct health-economic models, oversee evidence generation including real-world data, and shape pricing and market access frameworks aligning with payer and HTA requirements across regions. Collaborate closely with Clinical Development and Commercial teams to align evidence strategies with product lifecycle, indications, and market needs. Manage external HEOR vendors, oversee evidence infrastructure, and engage stakeholders such as payers, HTA bodies, and academic partners. Requirements: advanced degree (PhD, PharmD, MD, MPH, MSc, MBA) in health economics or related field; 15+ years in pharmacoeconomics, outcomes research, or health policy within the biopharma industry; proven experience in health technology assessment, pricing strategies, and managing international vendor relationships. HighValue: expertise in rare and high-value therapies, gene therapy modalities, and global reimbursement landscapes. WorkSetup: global scope with strategic influence across markets; location details not specified.